Beta-cyclodextrins conjugated magnetic Fe3O4 colloidal nanoclusters for the loading and release of hydrophobic molecule
Source abstract
Abstract
Abstract Herein, we report a facile method to prepare beta-cyclodextrin (β-CD)-conjugated magnetic Fe3O4 colloidal nanocrystal clusters (Fe3O4@GLY-CD) using (3-glycidyloxypropyl) trimethoxysilane (GLY) as the intermediate linker. The resulting Fe3O4@GLY-CD was characterized by several methods including Fourier transform infrared (FT-IR) spectroscopy, field-emission scanning electron microscopy (SEM), transmission electron microscopy (TEM), dynamic light scattering (DLS), X-ray diffraction (XRD), thermogravimetric analysis (TGA) and vibrating sample magnetometer (VSM). In addition, the loading and release properties of the synthesized Fe3O4@GLY-CD for the hydrophobic molecule 8-anilino-1-naphthalenesulfonic acid ammonium salt (ANS) were also investigated. The results show that the Fe3O4@GLY-CD has a spherical structure with an average diameter of 186 nm and high saturated magnetism of 51.2 emu/g. The grafting of β-CD onto Fe3O4 colloidal nanocrystal clusters can markedly increase the loading capacity of ANS because of β-CD/ANS inclusion complex formation. The in vitro delivery profile shows that the release of ANS from the Fe3O4@GLY-CD nanosystem exhibits an initial burst followed by a slow and steady release. Moreover, Fe3O4@GLY-CD also demonstrates a temperature-dependent release behavior for ANS owing to the effect of temperature on the association constants of β-CD/ANS inclusion complexes. The developed magnetic hybrid nanomaterial is expected to find potential applications in several fields including separation science and biomedicine.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Protein Interaction Studies and Fluorescence Analysis · Characterization and Applications of Magnetic Nanoparticles
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. Colloidal nanocrystal synthesis and the organic–inorganic interface10.1038/nature04165 ↗
2. Colloidal nanoparticle clusters: functional materials by design10.1039/c2cs35197h ↗
3. Monodisperse magnetic single crystal ferrite microspheres10.1002/anie.200462551 ↗
4. Superparamagnetic magnetite colloidal nanocrystal clusters10.1002/anie.200700197 ↗
5. Highly water-dispersible biocompatible magnetite particles with low cytotoxicity stabilized by citrate groups10.1002/anie.200901566 ↗
6. Magnetic colloidal supraparticles: design, fabrication and biomedical applications10.1002/adma.201301896 ↗
7. One-step solvothermal synthesis of highly water-soluble, negatively charged superparamagnetic Fe3O4 colloidal nanocrystal clusters10.1039/c3nr00931a ↗
8. Controllable synthesis of hierarchical porous Fe3O4 particles mediated by poly(diallyldimethylammonium chloride) and their application in arsenic removal10.1021/am403533v ↗
9. Growth-dissolution-regrowth transitions of Fe3O4 nanoparticles as building blocks for 3D magnetic nanoparticle clusters under hydrothermal conditions10.1021/la403577y ↗
10. Biopolymer-directed synthesis of high-surface-area magnetite colloidal nanocrystal clusters for dual drug delivery in prostate cancer10.1039/c2jm34877b ↗
11. Hollow-core magnetic colloidal nanocrystal clusters with ligand-exchanged surface modification as delivery vehicles for targeted and stimuli-responsive drug release10.1002/chem.201202249 ↗
12. One-pot solvothermal synthesis of highly water-dispersible size-tunable functionalized magnetite nanocrystal clusters for lipase immobilization10.1002/asia.201300026 ↗
13. Magnetic nanoparticles: synthesis, protection, functionalization, and application10.1002/anie.200602866 ↗
14. β-Cyclodextrin conjugated magnetic nanoparticles for diazepam removal from blood10.1039/c1cc11855b ↗
15. Redox-responsive molecular nanoreservoirs for controlled intracellular anticancer drug delivery based on magnetic nanoparticles10.1002/adma.201103458 ↗
16. Synthesis of water-dispersible Fe3O4@β-cyclodextrin by plasma-induced grafting technique for pollutant treatment10.1016/j.cej.2013.06.016 ↗
17. Epidemiological studies of radio-frequency radiation: current status and areas of concern10.1016/0048-9697(95)04914-2 ↗
18. D.W. Armstrong, US Patent No. 4,539,399 (1985).
19. Cyclodextrin silica-based materials: advanced characterizations and study of their complexing behavior by diffuse reflectance UV–vis spectroscopy10.1016/j.micromeso.2004.07.005 ↗
20. Magnetic nanoparticles grafted with cyclodextrin for hydrophobic drug delivery10.1021/cm702278u ↗
21. Cyclodextrin conjugated magnetic colloidal nanoparticles as a nanocarrier for targeted anticancer drug delivery10.1088/0957-4484/19/26/265602 ↗
22. Maltodextrin-modified magnetic microspheres for selective enrichment of maltose binding proteins10.1021/am405773m ↗
23. Inclusional complexation by cyclodextrin–polymer conjugates in organic solvents10.1021/ma9803739 ↗
24. An autonomous phase transition-complexation/decomplexation polymer system with a molecular recognition property10.1021/ma052509q ↗
25. Cyclodextrin gels which have a temperature responsiveness10.1002/(SICI)1099-0518(199706)35:8<1535::AID-POLA22>3.0.CO;2-7 ↗
26. Molecular-recognition-induced phase transitions of two thermo-responsive polymers with pendent β-cyclodextrin groups10.1002/macp.200700359 ↗
27. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release10.1016/j.ijpharm.2013.02.024 ↗
28. Enantiomeric separation of amino acids derivatized with fluoresceine isothiocyanate isomer I by micellar electrokinetic chromatography using β- and γ-cyclodextrins as chiral selectors10.1002/(SICI)1522-2683(19990601)20:7<1538::AID-ELPS1538>3.0.CO;2-1 ↗
29. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect10.1021/am100237p ↗